Form 4: Procept BioRobotics Director Taylor C. Harris Reports Stock Transactions

Director Taylor C. Harris reports acquisition and disposal of Procept BioRobotics Corp (PRCT) common stock and stock options.

Summary

• On June 4, 2024, Taylor C. Harris, a director of Procept BioRobotics Corp, reported transactions involving the company's stock.
• Harris acquired 81,550 shares of common stock through the exercise of stock options at a price of $5.18 per share.
• Simultaneously, Harris disposed of 81,550 shares of common stock.
• Harris also acquired 1,376 restricted stock units (RSUs).
• Following these transactions, Harris directly owns 132,712 shares of Procept BioRobotics Corp.
• Harris also acquired 2,526 stock options with an exercise price of $67.29.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of stock transactions. The exercise of options and acquisition of RSUs can be seen as a positive sign, but the simultaneous disposal of shares offsets this.

Positives

• The acquisition of restricted stock units (RSUs) indicates a continued alignment of the director's interests with the company's long-term performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company directors.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider trading activities.
• The vesting schedules and option exercise prices are typical components of executive compensation packages in the biotech industry.

Stakeholder Impact

• The transactions may have a minor impact on shareholder sentiment, depending on how they interpret the director's actions.

Key Dates